Aradigm Corporation announced consolidated financial results for the fourth quarter and full year ended December 31, 2016. For the quarter, the company reported total revenue of $9,000 against $35,000 a year ago. Loss from operations was $7,079,000 against $9,341,000 a year ago. Net loss and comprehensive loss was $7,937,000 or $0.54 per share basic and diluted against $9,352,000 or $0.63 per share basic and diluted a year ago. For the year, the company reported total revenue of $195,000 against $23,429,000 a year ago. Loss from operations was $30,022,000 against $17,152,000 a year ago. Net loss and comprehensive loss was $32,938,000 or $2.23 per share basic and diluted against net loss and comprehensive loss of $17,209,000 or $1.17 per share basic and diluted a year ago. The decrease in revenue was due to full utilization in 2015 of the $65 million of Grifols-funded budget for Pulmaquin project-related costs which are recognized as revenue under the Grifols collaboration arrangement.